Antibody Discovery Market expected to reach $15.79 billion by 2030 at 10.1% CAGR

Global Antibody Discovery Market

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Antibody Discovery Market Over The Period 2026–2030?

The antibody discovery market has observed significant expansion in recent years. It is anticipated to grow from $9.78 billion in 2025 to $10.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.8%. The historical increase in this market can be attributed to factors such as augmented research and development investments in antibody discovery, the rising occurrence of infectious and chronic illnesses, advancements in hybridoma technology, government financial support for biotechnology research, and collaborations established between academic institutions and pharmaceutical entities.

The antibody discovery market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $15.79 billion by 2030, showing a compound annual growth rate (CAGR) of 10.1%. Several factors will drive this growth during the forecast period, including the increasing demand for personalized medicine, the incorporation of AI and ML into drug discovery, the expanding biologics market, the adoption of high-throughput screening platforms, and an intensified focus on immunotherapy and targeted therapies. Key trends expected over this period involve high-throughput screening methodologies, innovations in monoclonal antibodies, the development of personalized antibody therapeutics, the creation of multi-specific antibodies, and advances in synthetic antibody engineering.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13783&type=smp

What Underlying Factors Are Accelerating The Growth Of The Antibody Discovery Market?

The escalating demand for precision therapeutics is anticipated to boost the expansion of the antibody discovery market in the coming years. Also known as personalized therapeutics, precision therapeutics involves tailoring medical treatment strategies and interventions to align with the unique characteristics of each patient. Within precision therapeutics, antibody discovery plays a crucial role by facilitating the creation of targeted treatments, such as monoclonal antibodies. These are engineered to interact with disease-specific molecules or cells with high specificity and accuracy, leading to more effective and individualized patient care. A relevant illustration of this trend is the report from IQVIA Holdings Inc., a US-based provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries, which stated in March 2024 that global expenditure on cell and gene therapies reached $5.9 billion in 2023, reflecting a 38% increase compared to 2022. Consequently, the heightened requirement for precision therapeutics is expected to fuel the growth of the antibody discovery market.

How Is The Antibody Discovery Market Divided Into Its Major Segments?

The antibody discovery market covered in this report is segmented –

1) By Methods: Phage Display, Hybridoma, Other Methods

2) By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody

3) By End Users: Pharmaceutical And Biotechnology Industry, Research Laboratory, Academic Laboratory

Subsegments:

1) By Phage Display: Selection And Screening Techniques, Optimization Methods

2) By Hybridoma: Monoclonal Antibody Production, Screening And Selection Processes

3) By Other Methods: Transgenic Mouse Technology, B-Cell Engineering, Single-Cell Sorting Techniques

How Are Trends Transforming The Antibody Discovery Market Landscape?

Leading entities within the antibody discovery market are advancing cutting-edge technologies, including AI-driven computational platforms for antibody drug discovery, aiming to enhance the efficacy and accuracy of antibody development. An AI-based computational platform for antibody drug discovery employs artificial intelligence and computational methods to accelerate the discovery and refinement of therapeutic antibodies. For instance, in October 2023, SwiftPharma BV, a Belgium-based firm specializing in recombinant proteins from a unique plant-based system, unveiled an AI-powered antibody discovery platform. This innovative instrument integrates AI, big data, machine learning, and phage display methods to swiftly forecast highly specific and strong antibody-antigen interactions. This methodology, comparable to natural language processing, produces a wide array of antibody variations, empowering SwiftPharma to construct exhaustive antibody libraries effectively. Ultimately, this sophisticated system significantly speeds up the identification of promising antibody drug candidates.

Who Are The Prominent Organizations Shaping The Antibody Discovery Market?

Major companies operating in the antibody discovery market are Charles River Laboratories, WuXi Biologics, Genmab A/S, Evotec, ChemPartner, Aragen Life Science Pvt. Ltd., GenScript Technology Corporation, Biocytogen, Twist Bioscience, BioDuro-Sundia, Fairjourney Biologics S.A., Harbour BioMed, Rockland Immunochemicals, Creative Biolabs, Synbio Technologies, ImmunoPrecise, Ablexis, Myrio Therapeutics, Antibody Solutions, MabSilico

Read the full antibody discovery market report here:

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

Which Region Is Projected To Dominate The Antibody Discovery Market During The Forecast Period?

North America was the largest region in the antibody discovery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Antibody Discovery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13783&type=smp

Browse Through More Reports Similar to the Global Antibody Discovery Market 2026, By The Business Research Company

Antibody Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

Research Antibodie And Reagent Market Report 2026

https://www.thebusinessresearchcompany.com/report/research-antibodie-and-reagent-global-market-report

Next Generation Antibody Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/next-generation-antibody-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model